Clinical Findings, Treatment and Long-Term Outcome in 37 Cats with Non-Associative Immune-Mediated Hemolytic Anemia: A Retrospective Observational Study of Two Treatment Cohorts
Lisa-Maria Kulmer, Pavlos G. Doulidis, Iwan A. Burgener, Nicole Luckschander-Zeller · 2026
Read Clinical Findings, Treatment and Long-Term Outcome in 37 Cats with Non-Associative Immune-Mediated Hemolytic Anemia: A Retrospective Observational Study of Two Treatment Cohorts by Lisa-Maria Kulmer, Pavlos G. Doulidis, Iwan A. Burgener, Nicole Luckschander-Zeller (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13564724.txt.
Description
In cats, an immune attack on their own red blood cells is uncommon but often deadly, and treatment data are thin. The authors review 37 cases seen at one center over ten years, all meeting standard diagnostic criteria. Fifteen cats receive prednisolone alone, and 22 receive it with cyclosporin A added, with the choice left to the treating clinician. The study records clinical findings, side effects, relapses, and long-term outcomes for both groups.
Overall mortality is 24.3 percent, and every death comes within four weeks. Most cats survive the acute phase but need long suppressive treatment, and lasting remission without drugs is rare, seen in just two cats. Five cats relapse, mostly while still on treatment. Because the added drug goes mainly to sicker cats, the authors stress that the two groups cannot be fairly compared for efficacy. They call for prospective studies to settle the question.
Catalog record
| CREATOR | Lisa-Maria Kulmer, Pavlos G. Doulidis, Iwan A. Burgener, Nicole Luckschander-Zeller |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |